Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
FEBS Letters|August 24, 2017
The α1β1 region is crucial for biofilm enhancement activity of MTC28 in Mycobacterium smegmatisPrasun Kundu, Debabrata Dutta, Amit Kumar DasFEBS Letters|July 7, 2022
Mycobacterium tuberculosis low molecular weight T-cell antigen Mtb8.4 has heme-binding and fiber-forming propertiesRashika Singh, Prasun Kundu, Gourab Bhattacharje, et al.The FEBS Journal|April 7, 2023
Crystal structure of FadA2 thiolase from Mycobacterium tuberculosis and prediction of its substrate specificity and membrane-anchoring propertiesRashika Singh, Prasun Kundu, Vipin Kumar Mishra, et al.The Journal of Infectious Diseases|March 14, 2025
Miniaturized assay to evaluate Plasmodium cynomolgi and P. knowlesi as models for prioritizing P. vivax vaccine targetsSheena Dass, Prasun Kundu, Deboki Naskar, et al.The Journal of Biological Chemistry|May 19, 2016
Structure-based Epitope Mapping of Mycobacterium tuberculosis Secretary Antigen MTC28Prasun Kundu, Rupam Biswas, Somnath Mukherjee, et al.Plos Pathogens|July 1, 2021
Using Plasmodium knowlesi as a model for screening Plasmodium vivax blood-stage malaria vaccine targets reveals new candidatesDuncan N Ndegwa, Prasun Kundu, Jessica B Hostetler, et al.Nature Communications|September 14, 2023
The structure of a Plasmodium vivax Tryptophan Rich Antigen domain suggests a lipid binding function for a pan-Plasmodium multi-gene familyPrasun Kundu, Deboki Naskar, Shannon J McKie, et al.Nature Communications|October 28, 2018
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45Prasun Kundu, Anthony Semesi, Matthijs M Jore, et al.Plos Neglected Tropical Diseases|November 23, 2022
Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian AmazonTenzin Tashi, Aditi Upadhye, Prasun Kundu, et al.Immunity|August 17, 2022
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responsesBrandon McLeod, Moustafa T Mabrouk, Kazutoyo Miura, et al.Pageof 2